Multiparametric MRI: Prostate Cancer Detection, Staging, and Management
*Corresponding Author: Dr. Daniel Weiss, Department of Prostate Imaging, University of Basel, Switzerland, Email: d.weiss@prostad.chReceived Date: Aug 05, 2025 / Published Date: Aug 29, 2025
Citation: Weiss DD (2025) Multiparametric MRI: Prostate Cancer Detection, Staging, and Management. J Radiol 14: 719DOI: 10.4172/2167-7964.1000719
Copyright: © 2025 Dr. Daniel Weiss This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
Abstract
Multiparametric MRI (mpMRI) is a cornerstone in modern prostate cancer diagnostics, enhancing detection, staging, and guiding biopsies. This review covers key mpMRI sequences like DWI and DCE-MRI, standardized reporting (PI-RADS), and emerging AI applications. It also discusses MRI-guided biopsies, challenges in detecting specific tumor types, advanced techniques (MRS, DTI), and its role in active surveillance. The content emphasizes improved accuracy and clinical decision-making in prostate cancer management
